Menu

Toledo Water Back On After Toxic Scare

Citizens of Ohio’s fourth-largest city can drink from the tap again, but the root causes of the Lake Erie algal blooms that shut off the flow for two days remain.

Aug 5, 2014
Bob Grant

This satellite image shows the algal bloom that occured in Lake Erie in 2011.NASA EARTH OBSERVATORYAfter a parched weekend for more than 400,000 people in and around Toledo, Ohio, safe drinking water is again flowing from their taps, according to city officials. The two-day drinking water ban that started on Saturday (August 2) was prompted by high levels of microcystin—a toxin that can sicken people and kill pets—in Lake Erie, from which water is extracted and processed for municipal supplies. A toxic peptide, microcystin is produced by cyanobacteria, which tend to bloom in the shallow lake during summer months, thanks to phosphorus runoff from farms, fertilized lawns, cattle feedlots, and leaking septic systems.

“Our water is safe,” Toledo Mayor D. Michael Collins told reporters on Monday (August 4) before drinking a glass of tap water at a press conference to announce the lifting of the ban.

Officials still cautioned residents to cut back on non-essential water use, and urged home and business owners to flush their lines to clear any residual toxins in the lines.

Although algal blooms occur in Lake Erie every summer, they became particularly dangerous this year. “Weather conditions made it such that bloom was going right into the water intakes,” Jeffrey Reutter, head of the Ohio Sea Grant research lab, told the Associated Press. This was compounded by the fact that phosphorus levels in the lake have been climbing since the mid-1990s. “We’re right back to where we were in the ’70s,” when Lake Erie was considered heavily polluted, Reutter added.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.